EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Effects of routes, concentrations and genetic polymorphisms on posaconazole–tacrolimus interactions in allogeneic haematopoietic cell transplantation

Masatomo Kuno iD, Yusuke Okayama, Yukako Yasui, Wataru Shibata, Makoto Moriguchi, Yosuke Nakaya, Mirei Horiuchi, Kentaro Ido, Kazuki Sakatoku, Yosuke Makuuchi, Joji Nagasaki, Hiroshi Okamura und 8 weitere

British Journal of Clinical Pharmacology · 2025-11 · 91 (11) · 3288-3296

DOI: 10.1002/bcp.70264 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 03.09.2025. Verfasst von Masatomo Kuno und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Tacrolimus, Triazoles, Immunosuppressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is no prospective research on factors influencing posaconazole (PSCZ)‐tacrolimus (TAC) interactions. This prospective observational study analysed 30 allogeneic haematopoietic cell transplantation recipients: 19 started PSCZ while receiving oral ( n = 10) or intravenous (IV) TAC ( n = 9) and 11 switched from IV to oral TAC during PSCZ administration. Following PSCZ initiation, the median TAC dose reductions were 45% for oral and 39% for IV TAC. Oral TAC concentration‐to‐dose ratios (C/D) significantly increased over 2 weeks ( P < .01) and correlated with PSCZ concentrations ( ρ = 0.92, P < .01), whereas IV TAC C/D showed no significant changes or correlations. The median IV to oral TAC conversion ratio was 2.86. Linear regression analyses revealed significant associations between PSCZ concentrations and oral TAC C/D changes, CYP3A5 polymorphisms and IV TAC C/D changes, and CYP3A5 polymorphisms and TAC conversion ratios. TAC route, PSCZ concentrations and genetic polymorphisms may influence PSCZ–TAC interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationTacrolimusTriazolesImmunosuppressive AgentsCytochrome P-450 CYP3AAntifungal AgentsHumansMaleFemaleDrug InteractionsAdultMiddle AgedProspective StudiesPolymorphism, GeneticAdministration, OralYoung AdultAgedAdministration, IntravenousTransplantation, HomologousAdolescent

Stichwörter der Autor:innen

allogeneic haematopoietic cell transplantationdrug–drug interactionsgenetic polymorphismsposaconazoletacrolimus

Substanzen

posaconazoleTacrolimusTriazolesImmunosuppressive AgentsCytochrome P-450 CYP3ACYP3A5 protein, humanAntifungal Agents

Autor:innen und Institutionen

  • Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Hematology, Wakakusa-Daiichi Hospital, Osaka, Japan.
  • Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Pharmacy, Sakai City Medical Center, Osaka, Japan.
  • Department of Laboratory Medicine and Medical Informatics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University, Kyoto, Japan.

ORCID-Profile: Masatomo Kuno

Förderung

  • Japan Society for the Promotion of Science KAKENHI

Zitieren

APA

Kuno, M., Okayama, Y., Yasui, Y., Shibata, W., Moriguchi, M., Nakaya, Y., Horiuchi, M., Ido, K., Sakatoku, K., Makuuchi, Y., Nagasaki, J., Okamura, H., Nishimoto, M., Nakashima, Y., Nakamae, M., Yasui, H., Kakeya, H., Hino, M., Nakamae, H., & Miyagawa, H. (2025). Effects of routes, concentrations and genetic polymorphisms on posaconazole–tacrolimus interactions in allogeneic haematopoietic cell transplantation. British Journal of Clinical Pharmacology, 91(11), 3288-3296. https://doi.org/10.1002/bcp.70264

Vancouver

Kuno M, Okayama Y, Yasui Y, Shibata W, Moriguchi M, Nakaya Y, et al. Effects of routes, concentrations and genetic polymorphisms on posaconazole–tacrolimus interactions in allogeneic haematopoietic cell transplantation. British Journal of Clinical Pharmacology. 2025;91(11):3288-3296. doi:10.1002/bcp.70264

BibTeX
@article{Kuno2025,
  author = {Kuno, Masatomo and Okayama, Yusuke and Yasui, Yukako and Shibata, Wataru and Moriguchi, Makoto and Nakaya, Yosuke and Horiuchi, Mirei and Ido, Kentaro and Sakatoku, Kazuki and Makuuchi, Yosuke and Nagasaki, Joji and Okamura, Hiroshi and Nishimoto, Mitsutaka and Nakashima, Yasuhiro and Nakamae, Mika and Yasui, Hiroyuki and Kakeya, Hiroshi and Hino, Masayuki and Nakamae, Hirohisa and Miyagawa, Hideo},
  title = {Effects of routes, concentrations and genetic polymorphisms on posaconazole–tacrolimus interactions in allogeneic haematopoietic cell transplantation},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  volume = {91},
  number = {11},
  pages = {3288--3296},
  doi = {10.1002/bcp.70264}
}
Kostenlos starten →